失代偿期肝硬化患者照护者参与及负担与患者生活质量的关系
本研究基于PAL-LIVER集群随机试验,分析935例终末期肝病患者中559例与照护者共同入组者与单独入组者的患者报告结局差异。结果显示照护者共同入组与患者报告结局无关,但照护者高负担与基线生活质量更差、抑郁和症状更重独立相关。
要点
- 照护者共同入组与患者生活质量、抑郁及症状无显著关联
- 32%照护者存在高负担,与患者基线生活质量更差独立相关
- 高照护者负担未影响3个月时患者报告结局的改善
核心结论
- 在PAL-LIVER试验中,照护者共同入组与患者报告结局无关,但高照护者负担与基线患者报告结局更差独立相关,且不影响3个月时的改善。
研究设计与样本
- 对PAL-LIVER集群随机试验的二次分析,纳入19个美国中心的935例终末期肝病和/或肝细胞癌患者,559例与照护者共同入组。
- 照护者完成Zarit负担访谈-12,按<12或≥12分为低或高负担;患者在基线和3个月完成FACT-Hep、PHQ-9和ESAS-13。
主要发现
- 32%的照护者存在高负担。
- 有无照护者的患者FACT-Hep、PHQ-9和ESAS-13相似。
- 高照护者负担与更差的FACT-Hep、PHQ-9和ESAS-13相关。
- 调整患者性别、MELD和肝病诊断后,高照护者负担与FACT-Hep低11分、PHQ-9高3分、ESAS-13高13分相关。
- 3个月后所有患者报告结局均改善,但改善程度不因是否共同入组而异;高照护者负担组ESAS-13改善更大。
关键数值与推荐
- 照护者负担采用Zarit Burden Interview-12评估,<12为低负担,≥12为高负担。
- 患者报告结局工具包括FACT-Hep(生活质量)、PHQ-9(抑郁)和ESAS-13(症状)。
临床怎么用
- 临床应关注照护者负担,高负担照护者的患者基线生活质量更差、抑郁和症状更重。
- 针对减轻照护者负担的干预可能改善患者和照护者结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Informal caregivers are critical for the care of patients with end-stage liver disease (ESLD), but few studies have examined their impact on patient-reported outcome measures (PROMs). We aimed to describe the association between caregiver involvement, caregiver burden, and PROMs in a large ESLD cohort. METHODS: We analyzed the palliative care for liver diseases (PAL-LIVER) cluster randomized trial, which compared 2 models of palliative care for ESLD and/or hepatocellular carcinoma at 19 US sites. Patients who coenrolled with a caregiver were compared with those who enrolled alone. Caregivers completed the Zarit Burden Interview-12 and were classified as having a low or high burden (<12 or ≥12, respectively). Patients completed functional assessment of cancer therapy-hepatobiliary (FACT-Hep) (quality of life), Patient Health Questionnaire-9 (PHQ-9) (depression), and modified Edmonton Symptom Assessment Scale (ESAS-13) (symptoms) at baseline and at 3 months. RESULTS: Of 935 patients enrolled, 559 coenrolled with a caregiver. Notably, 32% of caregivers had a high burden. FACT-Hep, PHQ-9, and ESAS-13 were similar in those with and without a caregiver. High caregiver burden was associated with worse FACT-Hep, PHQ-9, and ESAS-13. Adjusting for patient sex, Model for End-Stage Liver Disease, and liver diagnosis, high caregiver burden was associated with 11-point lower FACT-Hep, 3-point higher PHQ-9, and 13-point higher ESAS-13. After 3 months, all PROMs improved, but improvements did not differ by coenrollment. ESAS-13 had greater improvement in dyads with high caregiver burden. DISCUSSION: In the PAL-LIVER trial, caregiver coenrollment was not associated with PROMs. High caregiver burden was associated with baseline PROMs, but did not affect PROMs at 3 months. Interventions targeted at relieving caregiver burden are urgently needed to improve both patient and caregiver outcomes.
引用
- Orman ES, Johnson AW, Rockey DC, et al. Caregiver Involvement and Burden and Patient Quality of Life in Patients With Decompensated Cirrhosis. Am J Gastroenterol. 2026. PMID: 42262375. doi:10.14309/ajg.0000000000004076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。